175 related articles for article (PubMed ID: 12145576)
1. [Positron emission-computed tomography in diagnosis and staging of lung neoplasms. Personal experience].
Mezzetti M; Calati AM; Schubert L
Minerva Chir; 2002 Aug; 57(4):461-5. PubMed ID: 12145576
[TBL] [Abstract][Full Text] [Related]
2. Does whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer?
Aquino SL; Fischman AJ
Chest; 2004 Sep; 126(3):755-60. PubMed ID: 15364753
[TBL] [Abstract][Full Text] [Related]
3. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
Bryant AS; Cerfolio RJ
Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527
[TBL] [Abstract][Full Text] [Related]
4. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic possibilities of positron emission tomography in oncologic pulmonology].
Fekésházy A; Miklovicz T; Esik O; Lengyel Z; Petrányi A; Koncz A
Orv Hetil; 2002 May; 143(21 Suppl 3):1265-8. PubMed ID: 12077911
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography with CT in the evaluation of non-small cell lung cancer in populations with a high prevalence of tuberculosis.
Low SY; Eng P; Keng GH; Ng DC
Respirology; 2006 Jan; 11(1):84-9. PubMed ID: 16423207
[TBL] [Abstract][Full Text] [Related]
7. Improvement of non-small-cell lung cancer staging by means of positron emission tomography.
Albes JM; Lietzenmayer R; Schott U; Schülen E; Wehrmann M; Ziemer G
Thorac Cardiovasc Surg; 1999 Feb; 47(1):42-7. PubMed ID: 10218620
[TBL] [Abstract][Full Text] [Related]
8. FDG-PET in staging lung cancer: how does it change the algorithm?
Verhagen AF; Bootsma GP; Tjan-Heijnen VC; van der Wilt GJ; Cox AL; Brouwer MH; Corstens FH; Oyen WJ
Lung Cancer; 2004 May; 44(2):175-81. PubMed ID: 15084382
[TBL] [Abstract][Full Text] [Related]
9. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.
Daniels CE; Lowe VJ; Aubry MC; Allen MS; Jett JR
Chest; 2007 Jan; 131(1):255-60. PubMed ID: 17218584
[TBL] [Abstract][Full Text] [Related]
10. Role of positron emission tomography in mediastinal lymphatic staging of non-small cell lung cancer.
Melek H; Gunluoglu MZ; Demir A; Akin H; Olcmen A; Dincer SI
Eur J Cardiothorac Surg; 2008 Feb; 33(2):294-9. PubMed ID: 18096398
[TBL] [Abstract][Full Text] [Related]
11. Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group Study.
De Leyn P; Stroobants S; De Wever W; Lerut T; Coosemans W; Decker G; Nafteux P; Van Raemdonck D; Mortelmans L; Nackaerts K; Vansteenkiste J
J Clin Oncol; 2006 Jul; 24(21):3333-9. PubMed ID: 16849747
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.
Lee ST; Berlangieri SU; Poon AM; Mitchell P; Pathmaraj K; Tabone K; Byrne AJ; O'Keefe GJ; Knight SR; Clarke CP; Scott AM
Intern Med J; 2007 Nov; 37(11):753-9. PubMed ID: 17517082
[TBL] [Abstract][Full Text] [Related]
13. The impact of thoracic computed tomography in clinically staged T1, N0, M0 chest lesions.
Becker GL; Whitlock WL; Schaefer PS; Tenholder MF
Arch Intern Med; 1990 Mar; 150(3):557-9. PubMed ID: 2310273
[TBL] [Abstract][Full Text] [Related]
14. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary meningioma: false-positive positron emission tomography for malignant pulmonary nodules.
Cura M; Smoak W; Dala R
Clin Nucl Med; 2002 Oct; 27(10):701-4. PubMed ID: 12352110
[TBL] [Abstract][Full Text] [Related]
16. Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients.
Takamochi K; Yoshida J; Murakami K; Niho S; Ishii G; Nishimura M; Nishiwaki Y; Suzuki K; Nagai K
Lung Cancer; 2005 Feb; 47(2):235-42. PubMed ID: 15639722
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer.
Meyers BF; Haddad F; Siegel BA; Zoole JB; Battafarano RJ; Veeramachaneni N; Cooper JD; Patterson GA
J Thorac Cardiovasc Surg; 2006 Apr; 131(4):822-9; discussion 822-9. PubMed ID: 16580440
[TBL] [Abstract][Full Text] [Related]
18. Economic analyses on the use of positron emission tomography for the work-up of solitary pulmonary nodules and for staging patients with non-small-cell-lung-cancer in Italy.
Gugiatti A; Grimaldi A; Rossetti C; Lucignani G; De Marchis D; Borgonovi E; Fazio F
Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):49-61. PubMed ID: 15195004
[TBL] [Abstract][Full Text] [Related]
19. Integrated positron emission tomography and computed tomography in preoperative lymph node staging of non-small cell lung cancer.
Xu N; Wang M; Zhu Z; Zhang Y; Jiao Y; Fang W
Chin Med J (Engl); 2014; 127(4):607-13. PubMed ID: 24534208
[TBL] [Abstract][Full Text] [Related]
20. Images in medicine. Positron emission tomography (PET) in the evaluation of a solitary pulmonary nodule.
Scheiner JD; Noto RB
Med Health R I; 2001 Apr; 84(4):132. PubMed ID: 11347350
[No Abstract] [Full Text] [Related]
[Next] [New Search]